Details

Autor(en) / Beteiligte

• Bhargava, Samir
• Dubey, Satya Prakash
• Haldipur, Deepak
• Hathiram, Bachi
• Jagtap, Charuhas
• Khattar, Vicky
• Kulkarni, Shriram Vasant
• Kotamkar, Ashwin
• Muralidharan, Parthasarathy
• Kumar, Pradeep
• Qamra, Amit
• Ramadhin, Abhishek
• Venkatraman, Sreenivasan

Titel

Management of Recurrent Aphthous Stomatitis: An Indian Expert Consensus

Ist Teil von

• Indian journal of otolaryngology, and head, and neck surgery, 2023-09, Vol.75 (3), p.2672-2680

Ort / Verlag

New Delhi: Springer India

Erscheinungsjahr

2023

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• Recurrent aphthous stomatitis (RAS) is characterized by painful, oral mucosal ulcers with wide range of prevalence ranging from 2 to 78%. Etiology of RAS is idiopathic and multifactorial. There are numerous gaps in assessment and management of RAS and the absence of guidelines or a consensus document makes the treatment further difficult. The aim of this document is to provide an Indian expert consensus for management of RAS. Experts from different specialties such as Otorhinolaryngology, Oral Medicine/Dentistry and Internal Medicine from India were invited for face to face and online meetings. After a deliberate discussion of current literature, evidence and clinical practice during advisory meetings, experts developed a consensus for management of RAS. We identify that the prevalence of RAS may lie between 2 and 5%. In defining RAS, we advocate three or more recurrences of aphthous ulcers per year as criterion for RAS. Investigation should include basic hematological (complete blood count) and nutritional (serum vitamin B12, and iron studies) parameters. Primary aim of treatment is to reduce the pain, accelerate ulcer healing, reduce the recurrences and improve the quality of life. In treating RAS, initial choice of medications is determined by pain intensity, number and size of ulcers and previous number of recurrences. Topical and systemic agents can be used in combination for effective relief. In conclusion, this consensus will help physicians and may harmonize effective diagnosis and treatment of RAS.